Clinical trials
Phase 4 Cardiovascular Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Completed | 7 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China National Center for Cardiovascular Diseases | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Abbott | 1 |
| Boehringer Ingelheim | 1 |
| China-Japan Friendship Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| Fudan University | 1 |
| General Hospital of Chinese Armed Police Forces | 1 |
| Guangzhou General Hospital of Guangzhou Military Command | 1 |
| Harbin Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 20 |
| Myocardial Infarction | 4 |
| Stroke | 4 |
| Dyslipidemias | 3 |
| Hypertension | 3 |
| Acute Coronary Syndrome | 2 |
| Cerebrovascular Disorders | 2 |
| Coronary Disease | 2 |
| Diabetes Mellitus | 2 |
| Embolism and Thrombosis | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.